456 related articles for article (PubMed ID: 17942737)
1. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.
Lodge DJ; Grace AA
J Neurosci; 2007 Oct; 27(42):11424-30. PubMed ID: 17942737
[TBL] [Abstract][Full Text] [Related]
2. Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.
Perez SM; Carreno FR; Frazer A; Lodge DJ
J Neurosci; 2014 Jul; 34(28):9261-7. PubMed ID: 25009259
[TBL] [Abstract][Full Text] [Related]
3. A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
Gill KM; Lodge DJ; Cook JM; Aras S; Grace AA
Neuropsychopharmacology; 2011 Aug; 36(9):1903-11. PubMed ID: 21562483
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.
Lodge DJ; Grace AA
Neurotox Res; 2008 Oct; 14(2-3):97-104. PubMed ID: 19073417
[TBL] [Abstract][Full Text] [Related]
5. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
Gill KM; Cook JM; Poe MM; Grace AA
Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
[TBL] [Abstract][Full Text] [Related]
6. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
Gill KM; Miller SA; Grace AA
Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
[TBL] [Abstract][Full Text] [Related]
7. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
Chen L; Perez SM; Lodge DJ
Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
[TBL] [Abstract][Full Text] [Related]
8. Adolescent stress contributes to aberrant dopamine signaling in a heritable rodent model of susceptibility.
Perez SM; Lodge DJ
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109701. PubMed ID: 31299274
[TBL] [Abstract][Full Text] [Related]
9. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
Gomes FV; Guimarães FS; Grace AA
Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
[TBL] [Abstract][Full Text] [Related]
10. Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats.
Zhu X; Grace AA
Biol Psychiatry; 2021 Feb; 89(3):298-307. PubMed ID: 33357630
[TBL] [Abstract][Full Text] [Related]
11. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
Lodge DJ; Grace AA
Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
[TBL] [Abstract][Full Text] [Related]
12. Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia.
Perez SM; Lodge DJ
J Pharmacol Exp Ther; 2012 Nov; 343(2):288-95. PubMed ID: 22859862
[TBL] [Abstract][Full Text] [Related]
13. Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity.
Perez SM; Lodge DJ
J Neurosci; 2018 Dec; 38(50):10607-10618. PubMed ID: 30355626
[TBL] [Abstract][Full Text] [Related]
14. Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction.
Esmaeili B; Grace AA
Neuropsychopharmacology; 2013 Sep; 38(10):1871-80. PubMed ID: 23471079
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.
Perez SM; Shah A; Asher A; Lodge DJ
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1331-9. PubMed ID: 23190686
[TBL] [Abstract][Full Text] [Related]
16. A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.
Shah A; Lodge DJ
Transl Psychiatry; 2013 Jan; 3(1):e215. PubMed ID: 23321812
[TBL] [Abstract][Full Text] [Related]
17. Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.
Sonnenschein SF; Grace AA
Neuropharmacology; 2020 Feb; 163():107632. PubMed ID: 31077730
[TBL] [Abstract][Full Text] [Related]
18. Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia.
Perez SM; Chen L; Lodge DJ
Psychoneuroendocrinology; 2014 Sep; 47():88-97. PubMed ID: 25001958
[TBL] [Abstract][Full Text] [Related]
19. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
Boley AM; Perez SM; Lodge DJ
Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
[TBL] [Abstract][Full Text] [Related]
20. α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.
Neves GA; Grace AA
Neuropsychopharmacology; 2018 Jul; 43(8):1712-1720. PubMed ID: 29695783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
